Resident Evil Reboot Shatters Box Office Records: Zach Cregger's Biggest Hit Yet!
A New Milestone for Resident Evil
The latest installment of the Resident Evil series has achieved a remarkable feat at the North American box office, officially marking it as the most successful film in director Zach Cregger’s career. This new adaptation has outperformed the domestic earnings of the 2025 horror film Weapons, establishing itself as a significant commercial triumph for Cregger.
Currently ranked tenth among new releases in North America, the film continues to draw audiences to theaters. On its sixth Friday, it generated an additional $850,000, bringing its total domestic earnings to an impressive $151.5 million. This follows its earlier success on the international stage, where it had already surpassed the lifetime earnings of Weapons weeks ago.
A Record-Breaking Theatrical Run
A Record-Breaking Theatrical Run
The speed at which this film reached its financial milestone is particularly impressive. While Weapons wrapped up its 91-day theatrical run with over $151.5 million in North America, the Resident Evil reboot achieved and exceeded that total in under 40 days. This swift revenue growth underscores the strong audience interest that has persisted since its release on September 18.
Industry experts predict that the gap between the two films will continue to widen as the current project enters its sixth weekend in theaters. With its current trajectory, the film is on track to reach even more financial milestones in the weeks ahead. The plot revolves around a courier tasked with delivering a package to a secluded hospital, only to find himself ensnared in a deadly outbreak, battling for survival against hordes of mutated creatures.
Context and Future Prospects
Context and Future Prospects
This achievement represents a significant milestone in Zach Cregger's career, as Resident Evil now stands as his highest-grossing film in both domestic and international markets. The film has shown consistent performance, even as it approaches the latter stages of its theatrical run.
As the film continues to screen, industry watchers are keenly observing its performance to see how much higher it can climb before exiting theaters. For now, this production marks a notable commercial high for the director, successfully navigating the competitive North American box office landscape to secure its place at the pinnacle of his filmography.